Literature DB >> 1751458

Plasma viscosity or erythrocyte sedimentation rate in the diagnosis of giant cell arteritis?

G P Brittain1, G G McIlwaine, J A Bell, J M Gibson.   

Abstract

Plasma viscosity (PV) has replaced the erythrocyte sedimentation rate (ESR) as a routine laboratory test in many hospitals. The finding of a normal PV but raised ESR in a case of biopsy proved giant cell arteritis (GCA) cast doubt on this substitution in cases of suspected GCA. To assess the equivalence of PV and ESR in the diagnosis of this disease 40 suspected cases were prospectively investigated with both tests. The correlation between the two tests was good (r = 0.742, p less than 0.0001). The substitution of one test for the other would appear to be justified in most cases of suspected GCA. In the presence of biopsy proved disease, however, the PV and ESR each produced 13.3% false negatives. These occurred both in combination with and independently of the other test showing that, when in error, the two tests may not be equivalent. In cases of doubt the performing of both PV and ESR tests together improves but does not achieve complete diagnostic accuracy. Clinical judgment based on careful assessment of all available symptoms and signs must remain the foundation of diagnosis.

Entities:  

Mesh:

Year:  1991        PMID: 1751458      PMCID: PMC1042520          DOI: 10.1136/bjo.75.11.656

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  29 in total

1.  TEMPORAL ARTERITIS.

Authors:  A G WHITFIELD; M BATEMAN; W T COOKE
Journal:  Br J Ophthalmol       Date:  1963-09       Impact factor: 4.638

2.  Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy.

Authors:  N C BIRKHEAD; H P WAGENER; R M SHICK
Journal:  J Am Med Assoc       Date:  1957-03-09

3.  Erythrocyte sedimentation rate and its relationship to hematocrit giant cell arteritis.

Authors:  D C Love; D K Berler; G J O'Dowd; J Z Brooks; R A Love
Journal:  Arch Ophthalmol       Date:  1988-03

4.  Automated measurement of plasma viscosity by capillary viscometer.

Authors:  B M Cooke; J Stuart
Journal:  J Clin Pathol       Date:  1988-11       Impact factor: 3.411

5.  Temporal arteritis in blacks.

Authors:  D C Love; J Rapkin; G R Lesser; B M Shmookler; M P Kolsky; B Jackson; W F Barth
Journal:  Ann Intern Med       Date:  1986-09       Impact factor: 25.391

6.  Erythrocyte sedimentation rate and its relationship to hematocrit in giant cell arteritis.

Authors:  D M Jacobson; T L Slamovits
Journal:  Arch Ophthalmol       Date:  1987-07

7.  Monitoring the acute phase response.

Authors:  J Stuart; S M Lewis
Journal:  BMJ       Date:  1988-11-05

8.  Anemia in temporal arteritis.

Authors:  J J Whitaker; A B Hagedorn; G L Pease
Journal:  Postgrad Med       Date:  1966-07       Impact factor: 3.840

Review 9.  Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature.

Authors:  R L Wong; J H Korn
Journal:  Am J Med       Date:  1986-05       Impact factor: 4.965

10.  Severe cardiac failure and leukoerythroblastic anaemia in a patient with giant cell arteritis.

Authors:  R J Unwin; D J Carmichael; W S Peart
Journal:  J R Soc Med       Date:  1988-01       Impact factor: 18.000

View more
  4 in total

1.  Clinical approach to optic neuropathies.

Authors:  Raed Behbehani
Journal:  Clin Ophthalmol       Date:  2007-09

2.  Non-infectious aortitis in an immunosuppressed renal transplant recipient with IgA nephropathy.

Authors:  Charlotte M Snead; Stephen C Crockett; Phillippa K Bailey
Journal:  BMJ Case Rep       Date:  2017-10-19

3.  Polymyalgia rheumatica, temporal arteritis and malignancy.

Authors:  C A Speed; I Haslock
Journal:  Postgrad Med J       Date:  1995-08       Impact factor: 2.401

4.  Diagnostic Accuracy of Symptoms, Physical Signs, and Laboratory Tests for Giant Cell Arteritis: A Systematic Review and Meta-analysis.

Authors:  Kornelis S M van der Geest; Maria Sandovici; Elisabeth Brouwer; Sarah L Mackie
Journal:  JAMA Intern Med       Date:  2020-10-01       Impact factor: 21.873

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.